1. Home
  2. NRXP vs NDLS Comparison

NRXP vs NDLS Comparison

Compare NRXP & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • NDLS
  • Stock Information
  • Founded
  • NRXP 2015
  • NDLS 1995
  • Country
  • NRXP United States
  • NDLS United States
  • Employees
  • NRXP N/A
  • NDLS N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • NRXP Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • NRXP 32.6M
  • NDLS 32.9M
  • IPO Year
  • NRXP N/A
  • NDLS 2013
  • Fundamental
  • Price
  • NRXP $3.05
  • NDLS $0.89
  • Analyst Decision
  • NRXP Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • NRXP 4
  • NDLS 2
  • Target Price
  • NRXP $28.50
  • NDLS $3.00
  • AVG Volume (30 Days)
  • NRXP 188.0K
  • NDLS 232.0K
  • Earning Date
  • NRXP 08-13-2025
  • NDLS 08-06-2025
  • Dividend Yield
  • NRXP N/A
  • NDLS N/A
  • EPS Growth
  • NRXP N/A
  • NDLS N/A
  • EPS
  • NRXP N/A
  • NDLS N/A
  • Revenue
  • NRXP N/A
  • NDLS $495,670,000.00
  • Revenue This Year
  • NRXP N/A
  • NDLS $5.37
  • Revenue Next Year
  • NRXP N/A
  • NDLS $0.68
  • P/E Ratio
  • NRXP N/A
  • NDLS N/A
  • Revenue Growth
  • NRXP N/A
  • NDLS N/A
  • 52 Week Low
  • NRXP $1.10
  • NDLS $0.55
  • 52 Week High
  • NRXP $6.01
  • NDLS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 43.40
  • NDLS 59.20
  • Support Level
  • NRXP $3.12
  • NDLS $0.80
  • Resistance Level
  • NRXP $3.53
  • NDLS $0.82
  • Average True Range (ATR)
  • NRXP 0.16
  • NDLS 0.09
  • MACD
  • NRXP -0.07
  • NDLS 0.02
  • Stochastic Oscillator
  • NRXP 3.92
  • NDLS 91.92

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: